Novotech Expands Services to China

Novotech, an Australian CRO with offices throughout Asia, announced the expansion of services to
China with a Novotech office in Shanghai, a wholly owned entity with local staff. Shanghai is the ninth Novotech office in Asia. Novotech Asia COO, Dr. John Moller said China is now the largest clinical trial destination in Asia, and the 5th largest in the world.